{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T01:29:20Z","timestamp":1791509360375,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","award":["AS-TM-115-01-03"],"award-info":[{"award-number":["AS-TM-115-01-03"]}],"id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["115L104309"],"award-info":[{"award-number":["115L104309"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006477","name":"National Taiwan University","doi-asserted-by":"publisher","award":["115L892804"],"award-info":[{"award-number":["115L892804"]}],"id":[{"id":"10.13039\/501100006477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["115-SS0020"],"award-info":[{"award-number":["115-SS0020"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council, Taiwan"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41590-026-02515-5","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T09:04:17Z","timestamp":1778576657000},"page":"1268-1281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Epigenetic reprogramming of T cell metabolism restores function and enhances anti-tumor immunity in lung cancer"],"prefix":"10.1038","volume":"27","author":[{"given":"Yi-Chieh","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Wei","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Yao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-8045","authenticated-orcid":false,"given":"Chia-Lang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-Wen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jhen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsiu","family":"Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-9347","authenticated-orcid":false,"given":"Hsuan-Hsuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2387-9353","authenticated-orcid":false,"given":"Yi-Fu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7369-2015","authenticated-orcid":false,"given":"Po-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1106-3898","authenticated-orcid":false,"given":"Hsiao-Jung","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Shan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Hsia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7206-5231","authenticated-orcid":false,"given":"Li-Chung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4504-5571","authenticated-orcid":false,"given":"Yen-Ling","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-481X","authenticated-orcid":false,"given":"Shih-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5664-9392","authenticated-orcid":false,"given":"Chong-Jen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7057-9084","authenticated-orcid":false,"given":"Hsing-Chen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"2515_CR1","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry, E. J. & Kurachi, M. Molecular and cellular insights into T cell exhaustion. Nat. Rev. Immunol. 15, 486\u2013499 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"2515_CR2","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","volume":"33","author":"DS Thommen","year":"2018","unstructured":"Thommen, D. S. & Schumacher, T. N. T Cell dysfunction in cancer. Cancer Cell 33, 547\u2013562 (2018).","journal-title":"Cancer Cell"},{"key":"2515_CR3","doi-asserted-by":"publisher","first-page":"E2776","DOI":"10.1073\/pnas.1620498114","volume":"114","author":"GP Mognol","year":"2017","unstructured":"Mognol, G. P. et al. Exhaustion-associated regulatory regions in CD8+ tumor-infiltrating T cells. Proc. Natl Acad. Sci. USA 114, E2776\u2013E2785 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2515_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2014.01.005","volume":"40","author":"A Crawford","year":"2014","unstructured":"Crawford, A. et al. Molecular and transcriptional basis of CD4+ T cell dysfunction during chronic infection. Immunity 40, 289\u2013302 (2014).","journal-title":"Immunity"},{"key":"2515_CR5","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1126\/science.aae0491","volume":"354","author":"DR Sen","year":"2016","unstructured":"Sen, D. R. et al. The epigenetic landscape of T cell exhaustion. Science 354, 1165\u20131169 (2016).","journal-title":"Science"},{"key":"2515_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry, E. J. et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27, 670\u2013684 (2007).","journal-title":"Immunity"},{"key":"2515_CR7","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.aaf2807","volume":"354","author":"KE Pauken","year":"2016","unstructured":"Pauken, K. E. et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science 354, 1160\u20131165 (2016).","journal-title":"Science"},{"key":"2515_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","volume":"170","author":"HE Ghoneim","year":"2017","unstructured":"Ghoneim, H. E. et al. De novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation. Cell 170, 142\u2013157.e19 (2017).","journal-title":"Cell"},{"key":"2515_CR9","doi-asserted-by":"publisher","first-page":"15016","DOI":"10.1073\/pnas.0801497105","volume":"105","author":"SD Blackburn","year":"2008","unstructured":"Blackburn, S. D., Shin, H., Freeman, G. J. & Wherry, E. J. Selective expansion of a subset of exhausted CD8 T cells by \u03b1PD-L1 blockade. Proc. Natl Acad. Sci. USA 105, 15016\u201315021 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2515_CR10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","volume":"171","author":"MJ Topper","year":"2017","unstructured":"Topper, M. J. et al. Epigenetic therapy ties MYC depletion to reversing immune evasion and treating lung cancer. Cell 171, 1284\u20131300.e21 (2017).","journal-title":"Cell"},{"key":"2515_CR11","doi-asserted-by":"publisher","first-page":"6031","DOI":"10.1158\/1078-0432.CCR-17-1201","volume":"23","author":"X Li","year":"2017","unstructured":"Li, X. et al. Increased IFN\u03b3+ T cells are responsible for the clinical responses of low-dose DNA-demethylating agent decitabine antitumor therapy. Clin. Cancer Res. 23, 6031\u20136043 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2515_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0266-5","author":"MJ Topper","year":"2019","unstructured":"Topper, M. J., Vaz, M., Marrone, K. A., Brahmer, J. R. & Baylin, S. B. The emerging role of epigenetic therapeutics in immuno-oncology. Nat. Rev. Clin. Oncol. https:\/\/doi.org\/10.1038\/s41571-019-0266-5 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2515_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1093\/annonc\/mdy050","volume":"29","author":"S Aspeslagh","year":"2018","unstructured":"Aspeslagh, S., Morel, D., Soria, J. C. & Postel-Vinay, S. Epigenetic modifiers as new immunomodulatory therapies in solid tumours. Ann. Oncol. 29, 812\u2013824 (2018).","journal-title":"Ann. Oncol."},{"key":"2515_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12929-022-00893-0","volume":"30","author":"FM Tien","year":"2023","unstructured":"Tien, F. M., Lu, H. H., Lin, S. Y. & Tsai, H. C. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities. J. Biomed. Sci. 30, 3 (2023).","journal-title":"J. Biomed. Sci."},{"key":"2515_CR15","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1038\/s41590-021-00975-5","volume":"22","author":"MS Abdel-Hakeem","year":"2021","unstructured":"Abdel-Hakeem, M. S. et al. Epigenetic scarring of exhausted T cells hinders memory differentiation upon eliminating chronic antigenic stimulation. Nat. Immunol. 22, 1008\u20131019 (2021).","journal-title":"Nat. Immunol."},{"key":"2515_CR16","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1084\/jem.20070784","volume":"204","author":"JR Almeida","year":"2007","unstructured":"Almeida, J. R. et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover. J. Exp. Med. 204, 2473\u20132485 (2007).","journal-title":"J. Exp. Med."},{"key":"2515_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1172\/JCI70510","volume":"124","author":"YL Chiu","year":"2014","unstructured":"Chiu, Y. L. et al. Sprouty-2 regulates HIV-specific T cell polyfunctionality. J. Clin. Invest. 124, 198\u2013208 (2014).","journal-title":"J. Clin. Invest."},{"key":"2515_CR18","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1182\/blood-2011-12-398321","volume":"120","author":"ZC Ding","year":"2012","unstructured":"Ding, Z. C. et al. Polyfunctional CD4+ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapy. Blood 120, 2229\u20132239 (2012).","journal-title":"Blood"},{"key":"2515_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22433-4","volume":"12","author":"RR Weng","year":"2021","unstructured":"Weng, R. R. et al. Epigenetic modulation of immune synaptic-cytoskeletal networks potentiates \u03b3\u03b4 T cell-mediated cytotoxicity in lung cancer. Nat. Commun. 12, 2163 (2021).","journal-title":"Nat. Commun."},{"key":"2515_CR20","doi-asserted-by":"crossref","unstructured":"Li, X. et al. Decitabine priming increases anti-PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models. J. Clin. Invest. 133, e165673 (2023).","DOI":"10.1172\/JCI165673"},{"key":"2515_CR21","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1172\/JCI86437","volume":"126","author":"Y Kagoya","year":"2016","unstructured":"Kagoya, Y. et al. BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. J. Clin. Invest. 126, 3479\u20133494 (2016).","journal-title":"J. Clin. Invest."},{"key":"2515_CR22","doi-asserted-by":"publisher","first-page":"e145459","DOI":"10.1172\/JCI145459","volume":"131","author":"W Kong","year":"2021","unstructured":"Kong, W. et al. BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia. J. Clin. Invest. 131, e145459 (2021).","journal-title":"J. Clin. Invest."},{"key":"2515_CR23","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1016\/j.celrep.2016.08.032","volume":"16","author":"H Zhu","year":"2016","unstructured":"Zhu, H. et al. BET bromodomain inhibition promotes anti-tumor immunity by suppressing PD-L1 expression. Cell Rep. 16, 2829\u20132837 (2016).","journal-title":"Cell Rep."},{"key":"2515_CR24","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1080\/15592294.2019.1656156","volume":"15","author":"J Chee","year":"2020","unstructured":"Chee, J. et al. Impaired T cell proliferation by ex vivo BET-inhibition impedes adoptive immunotherapy in a murine melanoma model. Epigenetics 15, 134\u2013144 (2020).","journal-title":"Epigenetics"},{"key":"2515_CR25","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4049\/immunohorizons.1900037","volume":"3","author":"P Georgiev","year":"2019","unstructured":"Georgiev, P. et al. BET bromodomain inhibition suppresses human T cell function. Immunohorizons 3, 294\u2013305 (2019).","journal-title":"Immunohorizons"},{"key":"2515_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46516-x","volume":"9","author":"HR Gibbons","year":"2019","unstructured":"Gibbons, H. R. et al. Bromodomain inhibitor JQ1 reversibly blocks IFN-\u03b3 production. Sci. Rep. 9, 10280 (2019).","journal-title":"Sci. Rep."},{"key":"2515_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27026-9","volume":"12","author":"ZY Huang","year":"2021","unstructured":"Huang, Z. Y. et al. Single-cell analysis of diverse immune phenotypes in malignant pleural effusion. Nat. Commun. 12, 6690 (2021).","journal-title":"Nat. Commun."},{"key":"2515_CR28","doi-asserted-by":"crossref","unstructured":"Principe, N. et al. Malignant pleural effusions\u2014a window into local anti-tumor T cell immunity? Front. Oncol. 11, 672747 (2021).","DOI":"10.3389\/fonc.2021.672747"},{"key":"2515_CR29","doi-asserted-by":"crossref","unstructured":"Buggert, M. et al. T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection. PLoS Pathog. 10, e1004251 (2014).","DOI":"10.1371\/journal.ppat.1004251"},{"key":"2515_CR30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M. A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"2515_CR31","doi-asserted-by":"publisher","first-page":"798S","DOI":"10.3945\/an.115.011221","volume":"7","author":"EA Ananieva","year":"2016","unstructured":"Ananieva, E. A., Powell, J. D. & Hutson, S. M. Leucine metabolism in T cell activation: mTOR signaling and beyond. Adv. Nutr. 7, 798S\u2013805S (2016).","journal-title":"Adv. Nutr."},{"key":"2515_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101170","volume":"47","author":"C Ma","year":"2021","unstructured":"Ma, C. et al. Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activation. Mol. Metab. 47, 101170 (2021).","journal-title":"Mol. Metab."},{"key":"2515_CR33","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"2515_CR34","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos, P. et al. Selective inhibition of BET bromodomains. Nature 468, 1067\u20131073 (2010).","journal-title":"Nature"},{"key":"2515_CR35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature22367","volume":"545","author":"M Philip","year":"2017","unstructured":"Philip, M. et al. Chromatin states define tumour-specific T cell dysfunction and reprogramming. Nature 545, 452\u2013456 (2017).","journal-title":"Nature"},{"key":"2515_CR36","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.1021\/acs.molpharmaceut.8b00554","volume":"15","author":"J Shi","year":"2018","unstructured":"Shi, J. et al. Potent activity of the bromodomain inhibitor OTX015 in multiple myeloma. Mol. Pharm. 15, 4139\u20134147 (2018).","journal-title":"Mol. Pharm."},{"key":"2515_CR37","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1158\/1078-0432.CCR-15-1449","volume":"22","author":"A Henssen","year":"2016","unstructured":"Henssen, A. et al. Targeting MYCN-driven transcription by BET-bromodomain inhibition. Clin. Cancer Res. 22, 2470\u20132481 (2016).","journal-title":"Clin. Cancer Res."},{"key":"2515_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejca.2018.12.020","volume":"109","author":"S Postel-Vinay","year":"2019","unstructured":"Postel-Vinay, S. et al. First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic\/pharmacodynamic relationship and early termination due to unexpected toxicity. Eur. J. Cancer 109, 103\u2013110 (2019).","journal-title":"Eur. J. Cancer"},{"key":"2515_CR39","doi-asserted-by":"publisher","first-page":"e196","DOI":"10.1016\/S2352-3026(16)00021-1","volume":"3","author":"S Amorim","year":"2016","unstructured":"Amorim, S. et al. Bromodomain inhibitor OTX015 in patients with lymphoma or multiple myeloma: a dose-escalation, open-label, pharmacokinetic, phase 1 study. Lancet Haematol. 3, e196\u2013e204 (2016).","journal-title":"Lancet Haematol."},{"key":"2515_CR40","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1158\/1078-0432.CCR-13-2281","volume":"20","author":"P Bandopadhayay","year":"2014","unstructured":"Bandopadhayay, P. et al. BET bromodomain inhibition of MYC-amplified medulloblastoma. Clin. Cancer Res. 20, 912\u2013925 (2014).","journal-title":"Clin. Cancer Res."},{"key":"2515_CR41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nature16508","volume":"529","author":"S Shu","year":"2016","unstructured":"Shu, S. et al. Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer. Nature 529, 413\u2013417 (2016).","journal-title":"Nature"},{"key":"2515_CR42","doi-asserted-by":"publisher","first-page":"16669","DOI":"10.1073\/pnas.1108190108","volume":"108","author":"JA Mertz","year":"2011","unstructured":"Mertz, J. A. et al. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc. Natl Acad. Sci. USA 108, 16669\u201316674 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2515_CR43","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","volume":"146","author":"JE Delmore","year":"2011","unstructured":"Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904\u2013917 (2011).","journal-title":"Cell"},{"key":"2515_CR44","doi-asserted-by":"publisher","first-page":"eabc4275","DOI":"10.1126\/sciadv.abc4275","volume":"6","author":"R Wu","year":"2020","unstructured":"Wu, R. et al. De novo synthesis and salvage pathway coordinately regulate polyamine homeostasis and determine T cell proliferation and function. Sci. Adv. 6, eabc4275 (2020).","journal-title":"Sci. Adv."},{"key":"2515_CR45","doi-asserted-by":"publisher","first-page":"e169308","DOI":"10.1172\/jci.insight.169308","volume":"8","author":"AG Elmarsafawi","year":"2023","unstructured":"Elmarsafawi, A. G. et al. Modulating the polyamine\/hypusine axis controls generation of CD8+ tissue-resident memory T cells. JCI Insight 8, e169308 (2023).","journal-title":"JCI Insight"},{"key":"2515_CR46","doi-asserted-by":"publisher","first-page":"4186","DOI":"10.1016\/j.cell.2021.06.007","volume":"184","author":"DJ Puleston","year":"2021","unstructured":"Puleston, D. J. et al. Polyamine metabolism is a central determinant of helper T cell lineage fidelity. Cell 184, 4186\u20134202.e20 (2021).","journal-title":"Cell"},{"key":"2515_CR47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/eji.202048784","volume":"51","author":"KL O\u2019Brien","year":"2021","unstructured":"O\u2019Brien, K. L. et al. De novo polyamine synthesis supports metabolic and functional responses in activated murine NK cells. Eur. J. Immunol. 51, 91\u2013102 (2021).","journal-title":"Eur. J. Immunol."},{"key":"2515_CR48","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/nu15081852","volume":"15","author":"S Senekowitsch","year":"2023","unstructured":"Senekowitsch, S. et al. High-dose spermidine supplementation does not increase spermidine levels in blood plasma and saliva of healthy adults: a randomized placebo-controlled pharmacokinetic and metabolomic study. Nutrients 15, 1852 (2023).","journal-title":"Nutrients"},{"key":"2515_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2024.09.012","volume":"132","author":"P Keohane","year":"2024","unstructured":"Keohane, P. et al. Supplementation of spermidine at 40 mg\/day has minimal effects on circulating polyamines: an exploratory double-blind randomized controlled trial in older men. Nutr. Res. 132, 1\u201314 (2024).","journal-title":"Nutr. Res."},{"key":"2515_CR50","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces, M. R. et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat. Methods 14, 959\u2013962 (2017).","journal-title":"Nat. Methods"}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02515-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02515-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:01:58Z","timestamp":1780351318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-026-02515-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2515"],"URL":"https:\/\/doi.org\/10.1038\/s41590-026-02515-5","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"17 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}